These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30070065)

  • 1. Clinical Cellular Therapeutics Accelerate Clot Formation.
    George MJ; Prabhakara K; Toledano-Furman NE; Wang YW; Gill BS; Wade CE; Olson SD; Cox CS
    Stem Cells Transl Med; 2018 Oct; 7(10):731-739. PubMed ID: 30070065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procoagulant activity of human mesenchymal stem cells.
    Christy BA; Herzig MC; Montgomery RK; Delavan C; Bynum JA; Reddoch KM; Cap AP
    J Trauma Acute Care Surg; 2017 Jul; 83(1 Suppl 1):S164-S169. PubMed ID: 28628602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procoagulant in vitro effects of clinical cellular therapeutics in a severely injured trauma population.
    George MJ; Prabhakara K; Toledano-Furman NE; Gill BS; Wade CE; Cotton BA; Cap AP; Olson SD; Cox CS
    Stem Cells Transl Med; 2020 Apr; 9(4):491-498. PubMed ID: 31903737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue factor over-expression by human pancreatic cancer cells BXPC3 is related to higher prothrombotic potential as compared to breast cancer cells MCF7.
    Gerotziafas GT; Galea V; Mbemba E; Khaterchi A; Sassi M; Baccouche H; Prengel C; van Dreden P; Hatmi M; Bernaudin JF; Elalamy I
    Thromb Res; 2012 Jun; 129(6):779-86. PubMed ID: 21917301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of Tissue Factor-Deficient Cell Transplants as a Novel Strategy for Improving Hemocompatibility of Human Bone Marrow Stromal Cells.
    Oeller M; Laner-Plamberger S; Hochmann S; Ketterl N; Feichtner M; Brachtl G; Hochreiter A; Scharler C; Bieler L; Romanelli P; Couillard-Despres S; Russe E; Schallmoser K; Strunk D
    Theranostics; 2018; 8(5):1421-1434. PubMed ID: 29507631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue factor up-regulation in proinflammatory conditions confers thrombin generation capacity to endothelial colony-forming cells without influencing non-coagulant properties in vitro.
    Cuccuini W; Poitevin S; Poitevin G; Dignat-George F; Cornillet-Lefebvre P; Sabatier F; Nguyen P
    J Thromb Haemost; 2010 Sep; 8(9):2042-52. PubMed ID: 20546120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-induced thrombin generation via procoagulant endothelial microparticles is independent of tissue factor activity.
    Lechner D; Kollars M; Gleiss A; Kyrle PA; Weltermann A
    J Thromb Haemost; 2007 Dec; 5(12):2445-52. PubMed ID: 17922809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procoagulant extracellular vesicles in amniotic fluid.
    Hell L; Wisgrill L; Ay C; Spittler A; Schwameis M; Jilma B; Pabinger I; Altevogt P; Thaler J
    Transl Res; 2017 Jun; 184():12-20.e1. PubMed ID: 28236427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procoagulant activity and phosphatidylserine of amniotic fluid cells.
    Zhou J; Liu S; Ma M; Hou J; Yu H; Lu C; Gilbert GE; Shi J
    Thromb Haemost; 2009 May; 101(5):845-51. PubMed ID: 19404537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of tissue factor in the procoagulant and antibacterial effects of human adipose-derived mesenchymal stem cells during pneumosepsis in mice.
    Perlee D; de Vos AF; Scicluna BP; Maag A; Mancheño P; de la Rosa O; Dalemans W; Florquin S; Van't Veer C; Lombardo E; van der Poll T
    Stem Cell Res Ther; 2019 Sep; 10(1):286. PubMed ID: 31547876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of the 78-kDa glucose-regulated protein/immunoglobulin-binding protein (GRP78/BiP) inhibits tissue factor procoagulant activity.
    Watson LM; Chan AK; Berry LR; Li J; Sood SK; Dickhout JG; Xu L; Werstuck GH; Bajzar L; Klamut HJ; Austin RC
    J Biol Chem; 2003 May; 278(19):17438-47. PubMed ID: 12621026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graft Product for Autologous Peripheral Blood Stem Cell Transplantation Enhances Thrombin Generation and Expresses Procoagulant Microparticles and Tissue Factor.
    Sidibe F; Spanoudaki A; Vanneaux V; Mbemba E; Larghero J; Van Dreden P; Lotz JP; Elalamy I; Larsen AK; Gerotziafas GT
    Clin Appl Thromb Hemost; 2018 May; 24(4):684-690. PubMed ID: 28681632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of an acidic environment on coagulation dynamics.
    Gissel M; Brummel-Ziedins KE; Butenas S; Pusateri AE; Mann KG; Orfeo T
    J Thromb Haemost; 2016 Oct; 14(10):2001-2010. PubMed ID: 27431334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation.
    Gerotziafas GT; Chakroun T; Depasse F; Arzoglou P; Samama MM; Elalamy I
    Thromb Haemost; 2004 May; 91(5):977-85. PubMed ID: 15116259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
    Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
    Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic characteristics of extracellular vesicles derived from prostate cancer cells.
    Al Saleh HA; Haas-Neill S; Al-Hashimi A; Kapoor A; Shayegan B; Austin RC; Al-Nedawi K
    Prostate; 2018 Sep; 78(13):953-961. PubMed ID: 29761522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro inhibition of factor XIII retards clot formation, reduces clot firmness, and increases fibrinolytic effects in whole blood.
    Jámbor C; Reul V; Schnider TW; Degiacomi P; Metzner H; Korte WC
    Anesth Analg; 2009 Oct; 109(4):1023-8. PubMed ID: 19762725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High availability of intravascular tissue factor in neonates.
    Cvirn G; Gruber HJ; Koestenberger M; Kutschera J; Wagner T; Ferstl U; Sedlmayr P; Juergens G; Gallistl S
    J Pediatr Hematol Oncol; 2007 May; 29(5):279-83. PubMed ID: 17483700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone Marrow-Derived Mesenchymal Stem Cells Have Innate Procoagulant Activity and Cause Microvascular Obstruction Following Intracoronary Delivery: Amelioration by Antithrombin Therapy.
    Gleeson BM; Martin K; Ali MT; Kumar AH; Pillai MG; Kumar SP; O'Sullivan JF; Whelan D; Stocca A; Khider W; Barry FP; O'Brien T; Caplice NM
    Stem Cells; 2015 Sep; 33(9):2726-37. PubMed ID: 25969127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tissue factor requirement in blood coagulation.
    Orfeo T; Butenas S; Brummel-Ziedins KE; Mann KG
    J Biol Chem; 2005 Dec; 280(52):42887-96. PubMed ID: 16215234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.